Overview

lanreotide


'lanreotide' can also refer to...

lanreotide

lanreotide n.

lanreotide n.

lanreotide n.

lanreotide n.

The use of lanreotide in the management of lymphorrhea after an aortic valve replacement

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

Combined lanreotide autogel and temozolomide therapy in progressive neuroendocrine tumours: the SONNET study

High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: Clinical and biological effects

SP012THE DIPAK 1 STUDY: BASELINE CHARACTERISTICS AND SHORT-TERM TREATMENT EFFECTS OF LANREOTIDE VERSUS STANDARD CARE IN PATIENTS WITH LATER STAGE ADPKD

Efficacy of lanreotide autogel/depot (LAN) vs placebo (PBO) for symptomatic control of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients from the ELECT study

Safety and efficacy of lanreotide autogel/depot (LAN) every 14 days for patients with pancreatic or midgut neuroendocrine tumours (NETs) progressing on LAN every 28 days: The prospective, international CLARINET FORTE study

Longer term efficacy of lanreotide autogel/depot (LAN) for symptomatic treatment of carcinoid syndrome (CS) in neuroendocrine tumor (NET) patients from the ELECT open label study

Long-term safety/tolerability of lanreotide autogel/depot (LAN) treatment for metastatic intestinal and pancreatic neuroendocrine tumours (NETs): Final results of the CLARINET open-label extension (OLE)

Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

Safety of lanreotide 120 mg ATG in combination with metformin in patients with advanced well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: The MetNET-2 trial

 

More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

(lan-ri-oh-tyd)

an analogue of somatostatin that is administered by injection to treat acromegaly and hormone-secreting neuroendocrine tumours. Trade name: Somatuline.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.